FDA Plans Two-Day Meeting On Off-Label Marketing
Executive Summary
The agency will gather stakeholders in November to discuss questions about the potential broader availability of off-label medical product information. FDA is in the process of overhauling its off-label communications policies.
You may also be interested in...
Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing
Attorneys involved with a recent court ruling favoring Vascular Solutions believe the verdict might give manufacturers more latitude to engage in truthful, non-misleading, off-label speech. But caution is necessary.
US FDA, NIST Join Forces To Improve Manufacturing, Prevent Drug And Device Shortages
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
US FDA Announces 99 New Or Updated Consensus Standards
The updates reflect changes to standards on medical electrical equipment and a wide range of device types.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: